Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free RPRX Stock Alerts

Royalty Pharma (RPRX) Dividend Yield, Date & History

Royalty Pharma logo
$51.65 +0.86 (+1.69%)
Closing price 04:00 PM Eastern
Extended Trading
$50.92 -0.73 (-1.42%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Royalty Pharma Dividend Summary

Dividend Yield
1.82%
Annual Dividend
$0.94
Next
Dividend Payment
Jun. 10
Dividend Increase
Track Record
5 Years
Annualized 5-Year
Dividend Growth
24.01%
Dividend Payout Ratio
63.95%

Royalty Pharma (RPRX) pays an annual dividend of $0.94 per share, with a dividend yield of 1.82%. The next quarterly payment of $0.2350 per share is scheduled for Wednesday, June 10, to investors who own the stock before the ex-dividend date of Friday, May 15. RPRX has grown its dividend for 5 consecutive years, with an average annual increase of 24.01% in the past 5 years. The company currently pays out 63.95% of its earnings and 19.35% of its cash flow as dividends.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Dividend History

RPRX Dividend Payments by Quarter

The chart below displays up to four years of Royalty Pharma's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

RPRX Dividend Yield Over Time

The chart below tracks Royalty Pharma's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

Royalty Pharma vs. The Competition

Compare Royalty Pharma's annual dividend and yield with averages for Medical and NASDAQ companies to evaluate its performance against the market.

TypeRoyalty PharmaMedical CompaniesNASDAQ Companies
Annual Dividend$0.94$0.07$1.59
Dividend Yield1.82%2.78%5.22%
Track Record5 years16 years10 years

Royalty Pharma Dividend Payout Ratio

Dividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.

TypePayout Ratio
Based on Trailing 12 Months of Earnings63.95%
Based on This Year's Estimate18.65%
Based on Next Year's Estimate17.18%
Based on Cashflow19.35%

Royalty Pharma Dividend History by Quarter

Export
AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
4/17/2026quarterly$0.2350 - 1.88%5/15/20265/15/20266/10/2026
1/9/2026quarterly$0.2350+$0.0150
6.82%		2.08%2/20/20262/20/20263/10/2026
10/17/2025quarterly$0.22 - 2.25%11/14/202511/14/202512/10/2025
7/18/2025quarterly$0.22 - 2.48%8/15/20258/15/20259/10/2025
4/21/2025quarterly$0.22 - 2.7%5/16/20255/16/20256/10/2025
1/9/2025quarterly$0.22+$0.01
4.76%		2.8%2/21/20252/21/20253/10/2025
10/11/2024quarterly$0.21 - 3%11/15/202411/15/202412/10/2024
7/17/2024quarterly$0.21 - 2.97%8/16/20248/16/20249/13/2024

This table shows Royalty Pharma's quarterly dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

Royalty Pharma Dividend - Frequently Asked Questions

The current dividend yield for Royalty Pharma is 1.82%. Learn more on RPRX's dividend yield history.

The annual dividend for RPRX shares is $0.94. Learn more on RPRX's annual dividend history.

Royalty Pharma pays quarterly dividends to shareholders.

Royalty Pharma's next quarterly dividend payment of $0.2350 per share will be made to shareholders on Wednesday, June 10, 2026.

Royalty Pharma's most recent quarterly dividend payment of $0.2350 per share was made to shareholders on Tuesday, March 10, 2026.

Royalty Pharma's next ex-dividend date is Friday, May 15, 2026.

Royalty Pharma's most recent ex-dividend date was Friday, February 20, 2026.

Over the past five years, the company's dividend has grown by an average of 24.01% per year.

Royalty Pharma has increased its dividend for the past 5 consecutive years.

The most recent change in the company's dividend was an increase of $0.0150 on Friday, January 9, 2026.

The dividend payout ratio for RPRX is:
  • 63.95% based on the trailing year of earnings
  • 18.65% based on this year's estimates
  • 17.18% based on next year's estimates
  • 19.35% based on cash flow

Royalty Pharma's dividend yield of 1.87% is lower than the average Medical company that issues a dividend. The company's 5 consecutive years of dividend growth shows that the company has a new, but growing committment to increase its dividend. Royalty Pharma's dividend payout ratio of 63.95% is at a healthy, sustainable level, below 75% of its earnings.

Looking at the stock as a whole, market analysts rate Royalty Pharma stock as a Buy, with forecasts suggesting positive growth potential despite some reservations.

Related Companies
Dividend Tools
Stock Lists

This page (NASDAQ:RPRX) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel